Global Domperidone Market Size To Worth USD 1.97 Billion By 2033 | CAGR of 3.85
Category: HealthcareGlobal Domperidone Market Size To Worth USD 1.97 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Domperidone Market Size is Expected to Grow from USD 1.35 Billion in 2023 to USD 1.97 Billion by 2033, at a CAGR of 3.85% during the Forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 250 pages with 120 Market data tables and figures & charts from the report on the "Global Domperidone Market Size, Share, and COVID-19 Impact Analysis, By Dosage Form (Oral Solution, Tablets, and Injection), By Route of Administration (Oral and Intravenous), By Indications (Nausea and Vomiting, Functional Dyspepsia, and Gastric Motility Disorders), By Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/domperidone-market
The domperidone market is a pharmaceutical sector that develops, produces, and commercializes domperidone medications for treating gastrointestinal disorders. These medications prevent sickness and address symptoms like heartburn, indigestion, vomiting, and nausea. Domperidone, a dopamine receptor antagonist, is used as a peristaltic stimulant and anti-emetic agent for conditions like dyspepsia, indigestion, epigastric pain, nausea, and vomiting. It also manages nausea and vomiting caused by other Parkinson's disease drugs. The market growth is driven by the increasing prevalence of postoperative nausea and vomiting and pregnancy-associated nausea and vomiting. Postoperative nausea and vomiting (PONV) are a common issue in surgeries, with prevalence rates of 31.4% and 16.8%, with higher rates during the first 24 hours in European countries. The market for domperidone is growing due to the increasing incidence of gastrointestinal disorders, increased awareness of digestive health, and improved access to healthcare services. Advancements in formulated and delivered medications are enhancing the effectiveness of domperidone and improving patient compliance. The rising use in developing countries is also driving market growth. However, a stringent regulatory framework limits the growth of the market.
The tablets segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the dosage form, the global domperidone market is categorized as oral solution, tablets, and injection. Among these, the tablets segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. This is attributed to improved stability, ease of administration, patient convenience, bioavailability, reduced microbial contamination risk, rapid dissolution rate, enhanced biopharmaceutical properties, and faster action onset.
The oral segment accounted for the highest market share in 2023 and is predicted to grow at a CAGR of 3.74% throughout the projected timeframe.
Based on the route of administration, the global domperidone market is categorized as oral and intravenous. Among these, the oral segment accounted for the highest market share in 2023 and is predicted to grow at a CAGR of 3.74% throughout the projected timeframe. This is driven by the cost-effectiveness of oral medications, their safe administration, patient compliance, targeted drug delivery, and ease of ingestion.
The gastric motility disorders segment accounted for the highest market share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe.
Based on the indications, the global domperidone market is categorized as nausea and vomiting, functional dyspepsia, and gastric motility disorders. Among these, the gastric motility disorders segment accounted for the highest market share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe. The segment's growth is fueled by the rising incidence of gastroparesis, sedentary habits, and the increasing occurrence of gastroesophageal reflux disease and achalasia.
The hospital pharmacies segment accounted for the highest market share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe.
Based on the distribution channel, the global domperidone market is categorized as retail pharmacies, online pharmacies, and hospital pharmacies. Among these, the hospital pharmacies segment accounted for the highest market share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe. This is attributed to the increasing number of admissions for inpatient services, the availability of a wide range of medications, and healthcare policies that provide facilities like Mediclaim and other government schemes.
North America is expected to hold the greatest share of the global domperidone market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global domperidone market over the forecast period. The US leads the domperidone market in North America, dominated by major pharmaceutical firms and clinical studies. The market is driven by an increase in gastrointestinal disorder cases and a focus on personalized medicine. In high birth rates, there is growing interest in using medication to induce lactation. Pharmaceutical companies are investing in research to develop innovative formulations, while competition fuels innovation and pricing tactics. The integration of technology in healthcare, such as telemedicine and e-pharmacies, enhances accessibility and is expected to drive market growth.
Asia Pacific is predicted to grow at the fastest CAGR throughout the estimated period. The demand for domperidone is fueled by the rising prevalence of gastrointestinal disorders and the expansion of healthcare infrastructure in countries like China and India. Additionally, government initiatives and policies promoting maternal and child health contribute to market growth by enhancing the accessibility and affordability of domperidone.
Major key players in the global domperidone market are Lupin Limited, Novartis AG, GlaxoSmithKline PLC, Mankind Pharma Limited, Merck Co., Ltd., SanofiAventisGroupe, Cadila Healthcare Limited, Abbott Laboratories, Eli Lilly and Company, AstraZeneca Plc, Torrent Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Pfizer In., and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In June 2023, Cadila Pharmaceuticals, a leading pharmaceutical company, announced the successful launch of 10 products. These groundbreaking additions to our portfolio offer advanced medications as solutions to address various abnormal medical conditions, which further improve the patients' care. Cadila developed Esiloc D capsules containing Esomeprazole EC and Domperidone EC to provide effective relief for gastrointestinal reflux disease (GERD).
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global domperidone market based on the below-mentioned segments:
Global Domperidone Market, By Dosage Form
- Oral Solution
- Tablets
- Injection
Global Domperidone Market, By Route of Administration
- Oral
- Intravenous
Global Domperidone Market, By Indications
- Nausea and Vomiting
- Functional Dyspepsia
- Gastric Motility Disorders
Global Domperidone Market, By Distribution Channel
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Global Domperidone Market, By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?